Skip to main content

Military Health System

Important Notice about Pharmacy Operations

Change Healthcare Cyberattack Impact on MHS Pharmacy Operations. Read the statement to learn more. 

Skip subpage navigation

Innovation and Evaluation

COVID-19, Respiratory Disease Surveillance and Forecasting

The Innovation and Evaluation Section is a crucial component of the Armed Forces Health Surveillance Division Integrated Biosurveillance Branch that provides vital predictive analytics about respiratory disease threats, including COVID-19.

In response to the COVID-19 pandemic, I&E developed a “Markets to Watch” product and an associated interactive dashboard that combines civilian and military data sources to highlight trends in COVID-19 activity and allow near real-time monitoring of DOD health status across Military Health System Markets.

I&E also generates one- to four-week forecasts of respiratory disease activity in MHS Markets, including COVID-19, COVID-like illness, influenza-like illness, and respiratory syncytial virus, in collaboration with external partners and CDC. Forecasting results are distributed weekly and uploaded to the AFHSD-IB Respiratory Disease Forecasting Dashboard. These data provide senior leaders with a crucial planning tool and allow them to anticipate potential threats to military health and readiness.


  • Data analysis and modeling capabilities for respiratory diseases of military relevance
  • Weekly updates highlight MHS Markets with increasing COVID-19 activity
  • Forecasts for several respiratory syndromes, including CLI, ILI, and RSV
  • Interactive dashboards for planning and resource allocation in the MHS
  • Weekly forecasting to anticipate increasing respiratory disease activity, which may impact military health and readiness

Learn more about these respiratory disease threats:

Last Updated: September 28, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery